Home » Newsletters » BioWorld Science

BioWorld Science

June 20, 2000

View Archived Issues

Licensing opportunity from NIH: method of refolding recombinant endostatin

Licensing opportunity from NIH: neuropeptide for pain regulation, blood pressure control

Maxim looking to acquire Cytovia

MedImmune and Alkermes to develop inhalable form of MAb targeting RSV

Periodontix and PPL Therapeutics successfully complete feasibility study for transgenic P-113

Phase III results reported for Hemolink in cardiac bypass patients

Dura to launch second Allergan product

Celera Genomics and Geron to collaborate on human pluripotent stem cell genomics

Celgene and Novartis d-methylphenidate license agreement now in effect

Cel-Sci begins another collaboration with the NCI

Millennium and Lilly extend cardiovascular collaboration

Advanced Life Sciences to develop natural melanoma treatment

Lanepitant proves ineffective in reducing osteoarthritis pain

North American Vaccine shareholders approve Baxter acquisition

Oncolytics successfully completes initial toxicology studies of Reolysin

TKT files BLA for Fabry's disease treatment

Synsorb Biotech highlights achievements of two lead products during Q1

Data presented at Sitges workshop support further clinical development of DAPD

DMP-450: phase I/II results suggest promising antiviral efficacy, favorable toxicity profile

Pfizer/Warner-Lambert merger completed

Combinations containing SJ-3366 prove additive to synergistic against HIV isolates

Itavastatin favorably affects lipid profile without influencing glucose metabolism in NIDDM

Calcilytic NPS-2143 demonstrates bone anabolic effects in ovariectomized rats

Water-soluble MMP inhibitors and their use reported by Aventis

Merck and Banyu jointly develop new agents for obesity and its complications

Early development projects at Aventis include new erythromycin antibiotics

Combination therapy for heart failure

Selective alpha1A-adrenoceptor antagonists with an oxazolidinone structure

Inhibitors of intracellular signal transduction discovered by Ariad

New antimicrobial mutilin derivatives and their use described in patent issued to SB

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.